BiotechTube
Home/Amneal Pharmaceuticals/Maryll W. Toufanian
MW

Maryll W. Toufanian

Senior Vice President, Regulatory Strategy and Government Affairs

Amneal Pharmaceuticals

Therapeutic Areas

OncologyNeurology (CNS)GastroenterologyOphthalmologyRespiratoryEndocrine DisordersEmergency/Critical CarePsychiatryHematology

Amneal Pharmaceuticals Pipeline

DrugIndicationPhase
Brekiya (dihydroergotamine mesylate)Acute Treatment of Migraine & Cluster HeadacheApproved
CREXONT (Carbidopa/Levodopa)Parkinson's DiseaseApproved
Mesalamine DRGastroenterology (Ulcerative Colitis)Approved
EverolimusOncologyApproved
Epinephrine (Adrenalin generic)Emergency/Critical CarePending Approval
Prednisolone acetateOphthalmologyApproved
Risperidone ERPsychiatryApproved
Iohexol (Omnipaque generic)Diagnostic ImagingPending Approval

Leadership Team at Amneal Pharmaceuticals

CP
Chirag Patel
President and Co-Chief Executive Officer, Co-Founder
CP
Chintu Patel
Co-Chief Executive Officer, Co-Founder
TK
Tasos Konidaris
Executive Vice President, Chief Financial Officer
NS
Nikita Shah
Executive Vice President, Chief Human Resources Officer
JB
Jason B. Daly, Esq.
Executive Vice President, Chief Legal Officer & Corporate Secretary
GS
Gregory Sgammato
Senior Vice President, Corporate Development
AS
Andrew S. Boyer
Executive Vice President, Chief Commercial Officer – Generics & Biosciences
JR
Joe Renda
Senior Vice President, Chief Commercial Officer - Specialty
UK
Upendra Kumar Singh
President, India Business and Emerging Markets
SK
Srinivas Kone, PhD
Senior Vice President, Chief Scientific Officer – Generics
View full Amneal Pharmaceuticals profile